Xconomy

JULY 18, 2016

I would be ecstatic to have a simple tool for my patients that could detect cancers like ovarian and pancreatic that currently have no effective screening approach. The most popular approach is screening blood for circulating tumor DNA (ctDNA), which several companies claim to reliably detect at very low levels in the blood.

Screening 40

Screening Sample Tool Study 40

Xconomy

JUNE 10, 2016

The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. —At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Xconomy

SEPTEMBER 9, 2016

The agency advised women and their doctors not to use screening tests that claim to detect ovarian cancer. —One cancer screening test got positive news from a federal agency. Investors knocked about 30 percent off Dynavax’s share price last Friday, with only a modest recovery this week.

Pricing 40

Pricing Startup News Screening 40

Xconomy

APRIL 20, 2018

The price of drugs is certainly on a lot of minds these days, including the mind of President Trump, as he reportedly will make a. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients. Who will be able to afford all these options?

Pricing 52

Pricing News Report Develop 52